Vitamin D Treatment in Patients With Chronic Hepatitis C
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising
their vitamin D levels by adding it to their standard treament of Pegylated Interferon and
Ribavirin, there will be an increase in their sustained virological response.